However, a recent study demonstrated that a PAK2 inhibitor suppresses the migration and metastasis of TNBC cells through the inhibition of autophagy.[94] These conflicting results suggest that the effects of PAK2‐regulated autophagy markedly differ across various molecular subtypes of BC, further underscoring the heterogeneity of tumors. This evidence concerns the gene PAK2 and breast cancer.